Cardiff University

Researchers in the UK developed heritable Cas9-mediated mammalian genome editing that is acutely controlled by a cheap lysine derivative.

The collaborators aim to show that Cytox' VariaTect SNP profiling array and an associated algorithm can effectively predict the presence of Alzheimer's pathology.

Even in schizophrenia cases lacking intellectual disability, investigators found that rare mutations in genes normally resistant to loss-of-function changes were enriched.

Turn It Up or Down

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.

A collaborative effort involving four UK universities is attempting to provide communal compute, storage, algorithms, and pipelines for analyzing microbial genomes.

NEW YORK (GenomeWeb) – In Nature Genetics, members of the Marmoset Genome Sequencing and Analysis Consortium presented the first genome sequence established for the common marmoset, Callith

NEW YORK (GenomeWeb News) – Cardiff University scientists will use £6 million ($10 million) in funding to integrate and study genomic and environmental information from more than a million people and create a resource that could lead to new methods for assessing risk and personalized treatments f

NEW YORK (GenomeWeb News) – A pair of papers published online today in Nature described the outcome of two large exome sequencing studies aimed at finding new and/or rare genetic contributors to schizophrenia.

NEW YORK (GenomeWeb News) – Using a massive meta-analysis genome-wide association study approach, a large international team has unearthed 11 new loci with ties to late-onset Alzheimer's disease.

Pages

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.